Your browser doesn't support javascript.
loading
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
Liao, David S; Grossi, Federico V; El Mehdi, Delphine; Gerber, Monica R; Brown, David M; Heier, Jeffrey S; Wykoff, Charles C; Singerman, Lawrence J; Abraham, Prema; Grassmann, Felix; Nuernberg, Peter; Weber, Bernhard H F; Deschatelets, Pascal; Kim, Robert Y; Chung, Carol Y; Ribeiro, Ramiro M; Hamdani, Mohamed; Rosenfeld, Philip J; Boyer, David S; Slakter, Jason S; Francois, Cedric G.
Afiliação
  • Liao DS; Retina-Vitreous Associates Medical Group, Beverly Hills, California. Electronic address: dave_liao@laretina.com.
  • Grossi FV; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • El Mehdi D; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Gerber MR; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Brown DM; Vitreoretinal Consultants, Methodist Hospital, Houston, Texas.
  • Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts.
  • Wykoff CC; Retina Consultants of Houston, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas.
  • Singerman LJ; Retina Associates of Cleveland, Cleveland, Ohio.
  • Abraham P; Black Hills Regional Eye Institute, Rapid City, Iowa.
  • Grassmann F; Institute of Human Genetics, University of Regensburg, Regensburg, Germany; Karolinska Institutet, Stockholm, Sweden.
  • Nuernberg P; University of Cologne, Cologne, Germany.
  • Weber BHF; Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
  • Deschatelets P; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Kim RY; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Chung CY; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Ribeiro RM; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Hamdani M; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Rosenfeld PJ; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
  • Boyer DS; Retina-Vitreous Associates Medical Group, Los Angeles, California.
  • Slakter JS; Vitreous Retina Macula Consultants of New York, New York; New York University School of Medicine, New York, New York.
  • Francois CG; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
Ophthalmology ; 127(2): 186-195, 2020 02.
Article em En | MEDLINE | ID: mdl-31474439

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complemento C3 / Inativadores do Complemento / Atrofia Geográfica / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complemento C3 / Inativadores do Complemento / Atrofia Geográfica / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2020 Tipo de documento: Article